flufenamic acid (Compound)

Synonyms:flufenamic acid, 530-78-9, Arlef, Fluphenamic acid, Nichisedan, Achless, 2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid, Flufacid, Fullsafe, Lanceat, Paraflu, Plostene, Tecramine, Parlef, Parlif, Surika, Flufenaminsaeure, N-(3-Trifluoromethylphenyl)anthranilic acid, Reumajust A, Acido flufenamico, Ristogen, Sastridex, Ansatin, Meralen, Fluore-200, 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid, CI 440, NSC-82699, ANT-1, 3'-Trifluoromethyldiphenylamine-2-carboxylic acid, Acide flufenamique, CN-27,554, Acidum flufenamicum, Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, TVX 916, INF 1837, 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid, C.I. 440, 2-[3-(Trifluoromethyl)anilino]benzoic acid, INF-1837, NSC 219007, Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid, 2-((3-Trifluromethyl)phenyl)aminobenzoic acid, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID, N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid, NSC-219007, 60GCX7Y6BH, CHEMBL23588, MLS000028563, DTXSID7023063, CHEBI:42638, N-[3-(Trifluoromethyl)phenyl]anthranilic acid, Saal-F, CI-440, NCGC00016490-06, CAS-530-78-9, CN-27554, SMR000059027, N-(3-Trifluoromethylphenyl)-anthranilic acid, WLN: QVR BMR CXFFF, FFA, DTXCID303063, Flufenamicacid, N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid, Flufenaminsaeure [German], Acido flufenamico [Italian], FLF, CCRIS 5266, 2-[(3-Trifluromethyl)phenyl]aminobenzoic acid, N-[(3-Trifluoromethyl)phenyl]anthranilic acid, Acide flufenamique [INN-French], Acido flufenamico [INN-Spanish], Acidum flufenamicum [INN-Latin], N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid, N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid, N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid, SR-01000000241, EINECS 208-494-1, Anthranilic acid,.alpha.,.alpha.-trifluoro-m-tolyl)-, N-(.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid, UNII-60GCX7Y6BH, Flufenamic acid [USAN:INN:BAN:JAN], BRN 1996069, flufenamic-acid, Prestwick_220, MFCD00002422, Arlef (TN), Spectrum_001257, 1bm7, 2-(3-Trifluoromethylanilino)benzoic Acid, Opera_ID_578, Prestwick0_000203, Prestwick1_000203, Prestwick2_000203, Prestwick3_000203, Spectrum2_000789, Spectrum3_001273, Spectrum4_000102, Spectrum5_000686, EC 208-494-1, CBiol_001756, SCHEMBL17497, BSPBio_000185, BSPBio_001319, BSPBio_002866, CBDivE_012649, FLUFENAMIC ACID [MI], KBioGR_000039, KBioGR_000424, KBioGR_002267, KBioSS_000039, KBioSS_001737, KBioSS_002268, 3-14-00-00905 (Beilstein Handbook Reference), MLS001148610, DivK1c_000581, FLUFENAMIC ACID [INN], FLUFENAMIC ACID [JAN], SPECTRUM1501015, SPBio_000898, SPBio_002106, FLUFENAMIC ACID [USAN], BPBio1_000205, GTPL2447, FLUFENAMIC ACID [MART.], BCBcMAP01_000039, BDBM17636, HMS501N03, KBio1_000581, KBio2_000039, KBio2_001737, KBio2_002267, KBio2_002607, KBio2_004305, KBio2_004835, KBio2_005175, KBio2_006873, KBio2_007403, KBio3_000077, KBio3_000078, KBio3_002366, KBio3_002747, Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-, FLUFENAMIC ACID [WHO-DD], cMAP_000004, NINDS_000581, Bio1_000042, Bio1_000531, Bio1_001020, Bio2_000039, Bio2_000519, Flufenamic acid (JAN/USAN/INN), GLXC-27023, HMS1361B21, HMS1568J07, HMS1791B21, HMS1921B21, HMS1989B21, HMS2089E07, HMS2092B09, HMS2095J07, HMS2232G24, HMS3371F01, HMS3402B21, HMS3652F06, HMS3712J07, HMS3885P15, Pharmakon1600-01501015, HY-B1221, NSC82699, Tox21_110452, Tox21_302111, CCG-40167, NSC219007, NSC757823, s4268, STK985630, AKOS000265536, Tox21_110452_1, CS-4811, DB02266, KS-1143, NSC-757823, IDI1_000581, IDI1_033789, NCGC00016490-01, NCGC00016490-02, NCGC00016490-03, NCGC00016490-04, NCGC00016490-05, NCGC00016490-07, NCGC00016490-08, NCGC00016490-09, NCGC00016490-10, NCGC00016490-12, NCGC00023200-03, NCGC00023200-04, NCGC00023200-05, NCGC00023200-06, NCGC00023200-07, NCGC00255175-01, CN-27544, SBI-0051633.P002, DB-052254, 2-[3-(trifluoromethyl)anilino]-benzoic acid, AB00052198, FT-0603454, n-(a,a,a-trifluoro-m-tolyl)anthranilic acid, SW196528-3, T2354, UNM000001246003, 2-[3-(Trifluoromethyl)anilino]benzoic acid #, EN300-16858, 2-(3-(trifluoromethyl)phenylamino)benzoic acid, 2-[(3-Trifluoromethylphenyl)amino]benzoic Acid, A13333, D01581, D97458, AB00052198-14, AB00052198_15, Q416341, SR-01000000241-2, SR-01000000241-3, W-105772, BRD-K44067360-001-06-3, BRD-K44067360-001-16-2, Z56797275, F0909-0007, Flufenamic acid, analytical standard, for drug analysis, Anthranilic acid, N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-
Pubchem:PUBCHEM:3371
Id:c07a7898-b763-5e1f-8146-56add5443681
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View flufenamic acid's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for flufenamic acid.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with flufenamic acid.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.